Microbix Executes Substantial QAPs Supply Agreement
Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple Diseases...
Microbix Presenting Test Validation Methods at AACC
Usage of QAPs to Validate Whole Workflow Quality Control of Testing...
Microbix Reports Record Results for Q2 Fiscal 2022
Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million...
Microbix Presenting Omicron Test Control Results at CVS
QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant...
Microbix Presenting at the 2022 Bloom Burton Conference
Healthcare Investor Conference in Toronto on May 2 & 3, 2022...
Microbix Presenting Respiratory Virus Controls Data at Two Events
QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses...
Microbix Presenting HPV Product Results at EUROGIN
QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses...